Zacks Investment Research has recently initiated the coverage of ImmuCell Corporation (ICCC) with a “Neutral” recommendation. The Portland, ME-based company, founded in 1982, specializes in scientifically proven animal health products aimed at improving the health and productivity of dairy and beef cattle. This balanced outlook reflects the company's potential and the risks inherent in its operations and market environment.ImmuCell's market-leading First Defense product line stands out in the $75-million sc ...